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Background: The purpose of this research was to perform a scoping review of published literature on the validity
of administrative health data for ascertaining health conditions in the pediatric population (≤20 years).
Methods: A comprehensive search of OVID Medline (1946 - present), CINAHL (1937 - present) and EMBASE
(1947 - present) was conducted. Characteristics of validation studies that were abstracted included the study
population, health condition, topic of the validation (e.g., single diagnosis code versus case-finding algorithm),
administrative and validation data sources. Inter-rater agreement was measured using Cohen’s κ. Extracted data
were analyzed using descriptive statistics.
Results: A total of 37 articles met the study inclusion criteria. Cohen’s κ for study inclusion/exclusion and data
abstraction was 0.88 and 0.97, respectively. Most studies validated administrative data from the USA (43.2%) and
Canada (24.3%), and focused on inpatient records (67.6%). Case-finding algorithms (56.7%) were more frequently
validated than diagnoses codes alone (37.8%). Five conditions were validated in more than one study: diabetes
mellitus, inflammatory bowel disease, asthma, rotavirus infection, and tuberculosis.
Conclusions: This scoping review identified a number of gaps in the validation of administrative health data for
pediatric populations, including limited investigation of outpatient populations and older pediatric age groups.Background
Administrative health data, which are generated through
the routine delivery of health care programs [1], are rich
sources of population-based information for research
about population health and health services. However,
these data were not originally intended for research, lead-
ing to many questions about their validity for this purpose.
In particular, the use of diagnostic codes in these data,
which are typically recorded using the World Health
Organization’s International Classification of Diseases
(ICD), to accurately identify patient populations with
acute or chronic diseases has been the focus of multiple
validation studies. These studies compare individual
diagnostic codes or more complex case-finding algo-
rithms based on combinations of diagnosis codes and
other criteria in administrative health data to an exter-
nal data source, such as survey data, medical charts, or* Correspondence: natalie.shiff@usask.ca
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reproduction in any medium, provided the orlaboratory test results [2,3]. Validation studies and sys-
tematic reviews of validation studies [4-6] have primar-
ily focused on adult populations; there have been few
validation studies conducted in pediatric populations.
A recent review of the quality of validation studies
underscored the importance of population-specific
studies, because validity may be heterogeneous across
populations [7].
Age may be particularly important in the assessment
of diagnostic validity because pediatric and adult diseases
often differ [7]. For example, only five percent of pediatric
patients with juvenile idiopathic arthritis (formerly called
juvenile rheumatoid arthritis) have a disease pattern simi-
lar to the pattern observed in adult patients with rheuma-
toid arthritis [8], which may result in discrepant diagnostic
validity estimates between the two populations.
The purpose of this study was to synthesize the pub-
lished literature on the validity of diagnoses recorded in
administrative health data for the pediatric population
(≤20 years). This study was conducted to identify gaps in
the literature and opportunities for future research.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Type of study
Given that we did not identify any previous syntheses of
diagnostic validation studies for administrative health
data in the pediatric population, we conducted a scoping
review, which is intended to: (a) map an area of study,
(b) identify whether a full systematic review of the litera-
ture is warranted, (c) summarize and disseminate research,
and (d) identify gaps in the literature [9,10]. The primary
difference between a systematic review and a scoping
review is that in the latter, study quality is not the focus
of the evaluation [9,10], but in the former it is.
Literature search
The literature searches were conducted on October 22,
2012. The following electronic databases were com-
prehensively searched: OVID Medline (1946 - present),
CINAHL (1937 - present) and EMBASE (1947 - present).
These databases have been used in other systematic re-
views of validation studies about diagnostic codes in
administrative health databases [7]. Medline is a major
bibliographic database for clinical medicine and has its
origins in North America. CINAHL primarily indexesTable 1 Medline search strategy for scoping review
‘Validation study’ search terms ‘Pediatric population’ sea
1. validation studies [MeSH] 7. exp pediatrics [MeSH]
2. case definition*.mp. 8. *adolescent [MeSH] or ex
[MeSH] or exp infant [Me3. case validation.mp.
9. 7 or 84. “sensitivity and specificity” [MeSH] or




Note: MeSH =medical subject heading; .mp = keywords search of title, abstract, hea
.ti, ab = keyword search of title, abstract only; quotations = a phrase search; exp = us
indicates truncation (e.g., code* will retrieve “codes”, “code”, “coded”); *with a MeSHthe nursing and allied health journals, and includes mainly
North American journals as well as some European,
Asian, and Australasian journals. EMBASE is a major
biomedical and pharmaceutical database that indexes
international journals not represented in Medline or
CINAHL.
Three conceptual groupings of terms were used to define
the scope of this review: (a) validation study, (b) pediatric
population and (c) administrative health data. A validation
study can be characterized by its research method and out-
come measures of sensitivity, specificity, predictive value
and receiver operating characteristics. Administrative data
include admissions records, discharge data/records/claims/
abstracts, hospital records, outpatient records, inpatient
records, physician claims, billing data and medical rec-
ord linkage. Pediatric populations can be identified by
age group (e.g., infant, child, adolescent) and pediatrics
specialty.
A preliminary search of the published literature was
conducted and the words in the title, abstract, and subject
heading were used to develop the final search strategy.
This strategy was developed for Medline first (Table 1),
and then adapted for EMBASE and CINAHL. Key wordsrch terms ‘Administrative data’ search terms
10. medical record linkage [MeSH]
p child
SH]
11. “discharge claim*”.ab, ti.
12. discharge data.ab, ti.
13. “administrative data*”.ab, ti.
14. “hospital record*”.ab, ti.
15. “outpatient record*”.ab, ti.
16. “inpatient record*”.ab, ti.
17. “physician claim*”.ab, ti.
18. “Clinical Coding” [MeSH]
19. “International Classification of Diseases” [MeSH]
with/sn [Statistics & Numerical Data] subheading
20. (ICD9 or “ICD 9” or ICD-9).ab, ti.
21. (ICD10 or “ICD 10” or ICD-10).ab, ti.
22. “administrative billing code*”.ab, ti.
23. hospital-discharge data.ab, ti.
24. hospital billing data.ab, ti.
25. “discharge code*”.ab, ti.
26. “admissions record*”.ab, ti.
27. “discharge record*”.ab, ti.
28. “discharge abstract*”.ab, ti.
29. or/10-28
ding word, table of contents, key concepts, original title, tests & measures;
ed with a MeSH term to include all narrower MeSH terms; *after keyword
term indicates that the term is a major topic of the article.
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operators. No limits were placed on publication date or
type (e.g., journal article, systematic review). The reference
lists of all included articles were examined to identify
additional articles that may have been missed during
the database search.
The bibliographic information (e.g., title, authors,
abstract, subject headings, and website address [where
applicable]) was imported into Refworks bibliographic
management software for storage and removal of du-
plicate citations (http://www.refworks.com/).
Selection and data extraction
Following the removal of duplicate citations, a training
phase was used to ensure that study inclusion criteria were
consistently applied for a randomly selected subset of ap-
proximately 5% of the studies. A citation was included if:
(a) analyses were conducted for patients aged 0 to 20 years
of age, (b) results of primary research were reported in
peer reviewed publications, (c) it was published in English
as translation resources were not available, and (d) it was a
validation study of administrative health data. Administra-
tive health data differ from registries in that the latter refer
to data systems in which information about all cases of a
specified disease in a given population are recorded [11].
Examples include cancer registries, birth defect registries,
and twin registries. Studies about the validity of registries
were not included in the scoping review.
Following the training phase, two authors (NS and SJ)
applied the study inclusion criteria to another randomly
selected sample of 23 studies, and kappa was calculated
for the decision to include or exclude (yes or no). Both
authors extracted data from this validation set using a
standardized form. All data extracted by each of the
respective authors were then coded and pooled, and
kappa was calculated for the pooled results of the data
extraction. Subsequently, one investigator (SJ) applied
the inclusion criteria to all remaining studies and extracted
data from the retained studies.
The abstracted information included characteristics
of the citation (e.g., publication year), study population
(e.g., country of origin, age group and gender), health
condition(s) that were investigated, administrative health
data (e.g., the diagnosis codes or case finding algorithms
that were validated, type of data source, type of diagnostic
coding system), and the external data used to conduct the
validation.
Statistical analyses
Inter-rater agreement was assessed using Cohen’s κ [12]
for: (a) study inclusion and (b) data extraction. As well,
95% confidence intervals (CIs) were calculated. The data
were analyzed using descriptive statistics, including
frequencies and percentages.Results
A total of 1204 abstracts were identified by the literature
search (Figure 1). After removing duplicates, 817 unique
abstracts were screened for study inclusion. Fifteen were
excluded based only on the title and abstract (1.8%).
Thus, a total of 802 articles (98.2%) underwent full text
review. Of this number, 765 (95.4%) were excluded for the
following reasons (reasons are not mutually exclusive):
608 (75.8%) were not validation studies, 466 (58.1%) did
not use administrative health data, and 216 (26.9%) did
not conduct separate validation analyses for pediatric pa-
tients. Thirty-six articles met criteria for further analysis.
A hand search of the reference lists of included studies
identified one additional article, yielding a final sample of
37 articles. Cohen’s κ for study inclusion/exclusion and
data abstraction was 0.88 (95% CI 0.72, 1.00) and 0.97
(95% CI 0.94, 0.99), respectively.
The characteristics of included studies are summarized
in Table 2. Increasing numbers of validation studies were
published over time, with 11 (29.7%) published between
2006 and 2010 and a further 12 (32.4%) identified between
2011 and 2012 (up to the end of the search period). Just
over 40% of the studies (16 studies, 43.2%) were con-
ducted using administrative health data from the United
States, followed by Canada (9 studies, 24.3%). All valid-
ation studies included both males and females. There was
a trend of smaller numbers of validation studies as age in-
creased, with fewer studies (17 studies, 45.9%) including
individuals aged 16 to 20 years.
Slightly more than one-third of studies (14 studies,
37.8%) validated diagnosis codes, while more than half
evaluated case-finding algorithms (21 studies, 56.8%),
which use a combination of diagnosis codes and other
criteria (e.g., procedure codes) to identify cases with the
condition of interest. Two studies (5.4%) validated both
diagnosis codes and case-finding algorithms.
Only five conditions were investigated in more than
one study: diabetes (10.6%) [13-16], inflammatory bowel
disease (5.4%) [17,18], asthma (5.4%) [19,20], rotavirus
infection (5.4%) [21,22], and tuberculosis (5.4%) [23,24].
However, a diverse range of conditions were investigated
in single studies, including obesity [25], vaccine-related
illness [26], injuries [27], autism [28], febrile neutropenia
in oncology patients [29], high risk conditions [30],
dermatologic conditions [31-33], congenital anomalies
[34], cardiac defects [35], respiratory illnesses exclud-
ing asthma [36-38], neurologic conditions [39], other
gastrointestinal conditions [40-43], genitourinary con-
ditions [44,45], serum sickness [46], thrombosis [47],
maternal/perinatal conditions [48], and drug-related
anaphylaxis [49].
Administrative health data sources that were validated
consisted of inpatient (25 studies, 67.6%), outpatient (9
studies, 24.3%), and emergency room records (2 studies,
Abstracts identified from search strategy
N=1204
Abstracts remaining after removal of 
duplicates
N=817
Articles for full review after application of 
inclusion & exclusion criteria to abstracts
N=802
Articles deem ineligible after full review
N=765
*Reasons for exclusion: 
Not validation studies
(N = 608)
Did not use administrative health data
(N = 466)
Did not conduct separate pediatric analysis 
(N = 216)
Final number of articles included in 
scoping review
N=37
Number of articles added after review of 
reference lists
N=1
Figure 1 Scoping review process. The final review included 37
articles. *reasons for exclusion are not mutually exclusive.
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that validated individual diagnoses or case-finding algo-
rithms in a single database were most frequent (25 studies,67.6%). Eighty percent (20 studies) of the 25 studies that
validated data from a single administrative database
used inpatient administrative data (54.1% of 37 studies),
followed by outpatient administrative data (4 studies,
10.8% of 37 studies) and emergency department data
(1 study, 2.7% of 37 studies). Twelve studies (32.4% of
37 studies) validated information from multiple, linked
administrative data sources; five of these studies in-
cluded inpatient records (13.5% of 37 studies) and five
included outpatient records as one of the databases.
The main diagnosis coding systems that were validated
included ICD-9 or ICD-9 CM (28 studies, 75.7%) and
ICD-10 or ICD-10-CA (8 studies, 21.6%). The most fre-
quent external data sources used to validate administrative
data were medical charts (23 studies, 62.2%) and disease-
specific registry data (6 studies, 16.2%). Other validation
sources used included clinical databases, laboratory re-
cords, and survey data. Validation measures reported in-
clude sensitivity (24 studies, 64.8%), specificity (20 studies,
54.0%), positive predictive value (17 studies, 45.9%), and
negative predictive value (8 studies, 21.6%).Discussion
The prevalence of chronic pediatric conditions has in-
creased over recent decades; it is estimated that between
16% and 51% of children have at least one chronic condi-
tion [50-52]. Medical advances have improved survival for
conditions that were once fatal, resulting in an increasing
number of children with special healthcare needs [50-52].
In order to allow for resource planning and optimization
of care, the long-term outcomes of children and youth
with chronic conditions need to be determined, as does
their healthcare utilization [52]. Administrative health data
are an appropriate source to conduct long-term follow-up
studies, but validation studies are important to ensure that
true cases of disease can be ascertained in these data.
To the best of our knowledge, this is the first scoping
review to describe validation studies of administrative
health data in the pediatric population. Only a small
number of pediatric validation studies were identified,
whereas a recent systematic review about the quality of
reporting of administrative data validation studies that
included all age groups, identified 271 studies published
prior to June 2009 [7], most of which focused on the
adult population. The increasing number of pediatric
validation studies in recent years suggests that there is
growing recognition that pediatric populations are im-
portant to consider separately from adult populations
when validating administrative health data. The vast
majority of studies were conducted in North America,
reflecting a general trend for validation studies [4-6].
Most of the 37 studies included in this scoping review
validated complex case-finding algorithms that use a
Table 2 Characteristics of validation studies in the
scoping review
Study characteristic (N = 37) n (%)
Year of publication








New Zealand 3 (8.1)
China 2 (5.4)
United Kingdom 2 (5.4)
Other 2 (5.4)
Age group (years)a
0 - 5 29 (78.3)
6 - 10 21 (56.7)
11 - 15 29 (54.0)
16 - 20 17 (45.9)
Condition validated
Diabetes 4 (10.8)
Inflammatory bowel disease 2 (5.4)
Asthma 2 (5.4)




Diagnosis codes only 14 (37.8)





Emergency department 2 (5.3)
Pharmacy 2 (5.3)
Diagnosis coding systema
ICD-9 or ICD-9-CM 28 (75.7)
ICD-10 or ICD-10-CA 8 (21.6)
Other 2 (5.4)
Validation data sourcea
Medical chart 23 (62.2)
Disease registry 6 (16.2)
Clinical database 4 (10.8)
Table 2 Characteristics of validation studies in the
scoping review (Continued)








aCategories are not mutually exclusive; bPPV = positive predictive value;
cNPV = negative predictive value; dOther = correlation coefficient, relative risk
of association, kappa, percentage of agreement.
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data to ascertain disease cases.
Case-finding algorithms typically take advantage of
linked administrative health databases, whereas validation
of individual diagnoses may only take place in a single
administrative data source. In many administrative data
systems, data linkage creates the opportunity to evalu-
ate case-finding algorithms that will have sensitivity or
specificity that is greater than what can be observed by
examining a diagnosis in an unlinked database.
It is surprising that no validation studies were identified
for common chronic pediatric conditions such as atten-
tion deficit/hyperactivity disorder and obesity [50]. Only
diabetes, inflammatory bowel disease, asthma, tubercu-
losis, and rotavirus infection were validated in more than
one setting. It is well known that diabetes can be ascer-
tained from administrative health data with high specifi-
city and sensitivity for adult populations, which may have
contributed to increased interest in performing validation
studies for this diagnosis in the pediatric population. In
addition, with the growth in rates of juvenile diabetes, this
is an important condition for chronic disease research and
surveillance [50]. There is a gap in the literature for condi-
tions validated in the adults but not in the pediatric set-
ting. Rheumatoid arthritis is one example of a chronic
condition for which several validation studies have been
published in the adult population [53-55] but similar
validation studies are lacking in the pediatric age group.
In fact, no validation studies were found for chronic in-
flammatory arthritis in the pediatric population at the
time of this scoping review.
While this scoping review has several strengths, includ-
ing the breadth of citation databases investigated, the mul-
tiple health conditions that were included, and the range
of characteristics of the studies that were examined, it
does have some limitations. Only English language publi-
cations were included. Conference proceedings and arti-
cles that were not published in peer-review journals were
excluded. Publication bias may affect the generalizability
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taken together are not likely to result in a large number of
missing research studies, and hence cannot account for
the relative dearth of pediatric administrative data valid-
ation studies that were identified.
For conditions with several published validation stud-
ies in the pediatric population, such as diabetes, disease
specific systematic reviews evaluating the quality of stud-
ies should be examined, but only once more studies have
been published; at present, there are too few validation
studies in pediatric publications to warrant systematic
reviews. Many pediatric conditions are treated primarily
in an outpatient setting, and almost all chronic diseases
in this population require at least some outpatient care,
yet validation studies in this setting are lacking. Patients
with milder disease or better access to outpatient-based
services may never need hospitalization, and validation
studies primarily based on inpatient data likely do not
capture the true spectrum of chronic disease severity.
Validation studies in the outpatient setting can be challen-
ging to conduct due to small patient numbers in individ-
ual centres, lack of standardized charting, and difficulties
accessing medical records. As electronic medical records
become more widely available, this could potentially facili-
tate validation studies in the outpatient setting.
Conclusions
Numerous studies about the diagnostic validity of ad-
ministrative health data for the adult population have
been published [7], but studies about the pediatric popu-
lation have been limited in number and scope, despite
the fact that diagnoses may not be equally valid in both
populations. An increasing number of children are living
with chronic conditions. Administrative health data can
be used to estimate the burden of these conditions and
provide long-term outcomes data for studies about mor-
tality, health care utilization, and comorbid conditions.
In order for administrative data to serve these purposes,
their validity must be established. Our scoping review of
published literature on diagnostic validity of administra-
tive health data in the pediatric population revealed mul-
tiple gaps in the pediatric literature. Common chronic
pediatric conditions have not been validated in a mul-
tiple settings, the number of validation studies decreased
with increasing age within the pediatric population, and
although many pediatric conditions are treated primarily
in an outpatient setting, validation studies in this setting
are lacking. Further studies are needed to examine valid-
ity for a broad spectrum of pediatric health conditions,
in outpatient populations, and in both younger and older
age groups.
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